SecBot SecBot
EFFECT ·Filed Feb 27, 2026
MH

MHUAF

Meihua International Medical Technologies Co., Ltd.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC9999999995-26-000681
IPO/offering going effective
Actionable Insight • Neutral

Traders should monitor for future announcements regarding actual securities offerings, as the shelf registration creates a potential for near-term dilution. The lack of disclosed offering size means immediate financial impact is uncertain, but the ability to raise capital on short notice may influence sentiment if used aggressively.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MHUAF ▼ -17.78% at T+60d
NEUTRAL call -17.78% · α vs SPY -27.17% · entry $9.00 → $7.40
Entry = T+0 close
Feb 27, 2026
via day close
T+1d
-1.22%
call -1.22% · α -1.28%
$8.89
settled 8mo ago
T+5d
-14.67%
call -14.67% · α -12.68%
$7.68
settled 8mo ago
T+20d
-7.11%
call -7.11% · α +0.45%
$8.36
settled 7mo ago
T+60d
-17.78%
call -17.78% · α -27.17%
$7.40
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Meihua International Medical Technologies Co., Ltd. (MHUAF) has received an effectiveness notice from the SEC for its Form F-3 registration statement, allowing the company to begin offering securities immediately. This is a shelf registration, enabling the company to raise capital over time through various offerings without filing a new registration.

Key Facts

  • SEC has declared effective a Form F-3 registration statement (File No. 333-293682) for Meihua International Medical Technologies Co., Ltd.
  • Effectiveness date was February 26, 2026.
  • Form F-3 is a shelf registration, allowing the company to issue securities from time to time in one or more offerings.
  • No specific offering size, pricing, or use of proceeds details are disclosed in this filing.
  • Company is based in Yangzhou, China, and operates in the surgical and medical instruments sector.

Financial Impact

Not specified

dilutioncapital_structure

Risk Factors

  • Potential for unexpected equity issuance leading to share dilution
  • OTC-listed status may result in lower liquidity and higher volatility if an offering occurs

Market Snapshot

Exchange
OTC

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000681
Document: 9999999995-26-000681-index.html9999999995-26-000681
Document: 9999999995-26-000681.txt9999999995-26-000681
3 reports for MHUAF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MHUAF — sortable, filterable
TypeNow
Jun 26, 2026
17w ago
6-K
MIXED ★ 5/10
$8.70 $6.62▼ −23.91%▼ −26.96%$6.86 (−21.15%)
Apr 29, 2026
25w ago
20-F
BEARISH ★ 8/10
$8.88 $8.77▲ +1.24%▲ +5.35%$6.86 (+22.75%)
Feb 27, 2026
34w ago
EFFECT
NEUTRAL ★ 4/10
$9.00 $7.40▼ −17.78%▼ −27.17%$6.86 (−23.78%)
Showing 3 of 3

US Market Status

Market Closed — Opens Tue (17h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026